Huawei plans to lay off hundreds of U.S. employees following its ban
By Akshay Kedari  Date: 2019-07-15

Huawei plans to lay off hundreds of U.S. employees following its ban

The people who have been laid off would have the option to work for the company in China

Chinese tech giant, Huawei Technologies Co Ltd, plans to lay off a large number of people in the U.S. as the company struggles with its blacklisting in the country.

Apparently, jobs at the company’s research and development subsidiary in US, Futurewei Tech subsidiary, are also expected to be affected due to the layoffs. The unit employs around 850 people in the research labs all across the United States, sources familiar with the matter informed.

Citing sources, the layoffs are expected to be in hundreds, with probable option for the Chinese employees of Huawei in the U.S. to leave and stay with the company in their home country.

Reportedly, planned job cuts are expected to be announced soon while some employees at Huawei have been notified of their dismissal. Huawei has not disclosed the matter further.

According to reports, employees at Futurewei have faced major restrictions in order to communicate with their colleagues working in the home offices of Huawei located in China, sources stated. 

Wilbur Ross, U.S. Commerce Secretary said that licenses will be issued by the U.S. government to all the companies looking to sell goods to the Chinese giant where they will find no security threats.

For the record, the Trump administration reportedly blacklisted tech giant, Huawei along with over five dozen of the company’s affiliates from purchasing American components and technology owing to national security concerns. This could strictly hamper Huawei’s ability to create and develop advanced telecommunications products.

The U.S.-China trade war continues as Trump persuades Chinese govt. to change the old age industrial and trade policies. Apparently, Washington had increased its tariffs to 25 percent recently on $200 billion worth of products made in China as well as threatened to impose duties over almost every Chinese good later in the year. In a reaction to the move,  Beijing reportedly introduced its own retaliatory tariffs.

 

Source Credit- https://www.businessinsider.com/huawei-plans-extensive-layoffs-at-its-us-operations-wsj-2019-7?IR=T

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...